Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 318.00
-3.00 (-0.93%)
Jun 24, 2026, 11:30 AM JST
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 11.25 billion as of June 23, 2026. Its market cap has decreased by -7.44% in one year.
Market Cap
11.25B
Enterprise Value
9.17B
Revenue
323.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
318.00
Market Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 11.25B, a decrease of -52.61%. That is a compound annual growth rate of -13.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 11.25B | 62.77% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RaQualia Pharma | 12.39B |
| ReproCELL | 11.59B |
| CanBas | 10.61B |
| Immuno-Biological Laboratories | 8.77B |
| Kubota Pharmaceutical Holdings | 8.18B |
| Nano Holdings | 8.15B |
| CellSeed | 7.99B |
| OncoTherapy Science | 7.67B |